In C6 glioma cells, Aβ42 treatment induces cyclooxygenase-2 and inducible nitric oxide synthase (iNOS) overexpression followed by nuclear factor kappa B (NF-κB), which could be reversed by an anti-aggregatory compound resveratrol [86]. The gene discussed is NOS2; the disease is glioma.